SG’s Vickers Venture leads $13.2m funding in UK biotech startup SiSaf

SG’s Vickers Venture leads $13.2m funding in UK biotech startup SiSaf

Vickers Venture Partners chairman Finian Tan.

Singapore-based venture capital firm Vickers Venture Partners has led the $13.2-million Series B funding in SiSaf, a UK-headquartered biotech startup that develops drugs using Bio-Courier technology, according to an announcement.

The funding was also matched by Future Fund, the UK government’s fund that supports innovative businesses currently affected by COVID-19.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter